Back to Journals » Drug Design, Development and Therapy » Volume 13

Systemic taurine treatment provides neuroprotection against retinal photoreceptor degeneration and visual function impairments

Authors Tao Y, He M, Yang Q, Ma Z, Qu Y, Chen W, Peng G, Teng D

Received 11 November 2018

Accepted for publication 1 May 2019

Published 7 August 2019 Volume 2019:13 Pages 2689—2702


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Dr Tuo Deng

Ye Tao,*,1,2 Miao He,*,3 Qinghua Yang,1 Zhao Ma,3 Yingxin Qu,1 Wen Chen,3 Guanghua Peng,1 Dengke Teng4

1Department of Physiology, Basic Medical College, Zhengzhou University, Zhengzhou 450001, People’s Republic of China; 2Lab of Visual Cell Differentiation, Basic Medical College, Zhengzhou University, Zhengzhou 450001, People’s Republic of China; 3Department of Neurosurgery, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, People’s Republic of China; 4Department of Ultrasound, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China

*These authors contributed equally to this work

Objective: Retinitis pigmentosa causes progressive photoreceptor degeneration in the subjects while no clinical therapy exists. The present study sought to evaluate the potential protective effects of taurine on a pharmacologically induced RP animal model.
Methods: Photoreceptor degeneration in mice was induced by an intraperitoneal injection of N-methyl-N-nitrosourea (MNU). The MNU-administrated mouse received taurine treatment and then they were examined by electroretinography, spectral-domain optical coherence tomography, optokinetic test, and histological and immunohistochemistry assay.
Results: Prominent taurine deficiency was found in the retinas of MNU-administered mice. Intravenous taurine treatment increased significantly the retinal taurine level. Morphological studies showed that taurine could alleviate the retinal disorganizations in the MNU-induced mice. Taurine also ameliorated the visual impairments in the MNU-induced mice as evidenced by functional examinations. Immunostaining experiments demonstrated that both the M-cone and S-cone populations in the degenerative retinas are rescued by taurine. In particular, the M-cone photoreceptors in superior-temporal quadrant and the S-cone photoreceptors in inferior-nasal quadrant were preferentially rescued. Mechanism study showed that the photoreceptor apoptosis and oxidative stress in the degenerative retina were effectively alleviated by taurine treatment.
Conclusion: Taurine is protective against the MNU-induced photoreceptor degeneration. Systemic taurine administration may act as a promising therapeutic potion for retinopathies with chronic cycle.

Keywords: neural degeneration, retina, therapeutics

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]